Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Mortality of patients with solid and haematological cancers presenting with symptoms of COVID-19 with vs without detectable SARS-COV-2: a French nationwide prospective cohort study
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 125, Issue 5, Pages 658-671
Publisher
Springer Science and Business Media LLC
Online
2021-06-16
DOI
10.1038/s41416-021-01452-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Lymphopenia as a Biological Predictor of Outcomes in COVID-19 Patients: A Nationwide Cohort Study
- (2021) Jongmin Lee et al. Cancers
- Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
- (2021) Ivan O. Rosas et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk of COVID-19 for cancer patients
- (2020) Yang Xia et al. LANCET ONCOLOGY
- Risk of COVID-19 for patients with cancer
- (2020) Hanping Wang et al. LANCET ONCOLOGY
- Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
- (2020) Wenhua Liang et al. LANCET ONCOLOGY
- Clinical Characteristics of Coronavirus Disease 2019 in China
- (2020) Wei-jie Guan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variation in False-Negative Rate of Reverse Transcriptase Polymerase Chain Reaction–Based SARS-CoV-2 Tests by Time Since Exposure
- (2020) Lauren M. Kucirka et al. ANNALS OF INTERNAL MEDICINE
- Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China
- (2020) L. Zhang et al. ANNALS OF ONCOLOGY
- Do patients with cancer have a poorer prognosis of COVID-19? An experience in New York City
- (2020) H. Miyashita et al. ANNALS OF ONCOLOGY
- Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19
- (2020) M.L. Solodky et al. ANNALS OF ONCOLOGY
- TERAVOLT: Thoracic Cancers International COVID-19 Collaboration
- (2020) Jennifer G. Whisenant et al. CANCER CELL
- Risk Factors of Severe Disease and Efficacy of Treatment in Patients Infected with COVID-19: A Systematic Review, Meta-Analysis and Meta-Regression Analysis
- (2020) John J Y Zhang et al. CLINICAL INFECTIOUS DISEASES
- Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients
- (2020) Xiaohua Chen et al. CLINICAL INFECTIOUS DISEASES
- Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicenter) and outside Hubei (non-epicenter): A Nationwide Analysis of China
- (2020) Wen-hua Liang et al. EUROPEAN RESPIRATORY JOURNAL
- COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study
- (2020) Lennard Y W Lee et al. LANCET
- Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- (2020) Nicole M Kuderer et al. LANCET
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
- (2020) Vikas Mehta et al. Cancer Discovery
- SARS-CoV-2 Transmission in Patients With Cancer at a Tertiary Care Hospital in Wuhan, China
- (2020) Jing Yu et al. JAMA Oncology
- Managing cancer patients during the COVID-19 pandemic: An ESMO Interdisciplinary Expert Consensus
- (2020) G. Curigliano et al. ANNALS OF ONCOLOGY
- Outcomes of novel coronavirus disease 2019 (COVID‐19) infection in 107 patients with cancer from Wuhan, China
- (2020) Hongyan Zhang et al. CANCER
- Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)
- (2020) Florian Slimano et al. CANCER TREATMENT REVIEWS
- High mortality rate in cancer patients with symptoms of COVID-19 with or without detectable SARS-COV-2 on RT-PCR
- (2020) Souad Assaad et al. EUROPEAN JOURNAL OF CANCER
- Added value of chest CT in suspected COVID-19: an analysis of 239 patients
- (2020) Daniël A. Korevaar et al. EUROPEAN RESPIRATORY JOURNAL
- COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study
- (2020) Marina Chiara Garassino et al. LANCET ONCOLOGY
- Effect of delays in the 2-week-wait cancer referral pathway during the COVID-19 pandemic on cancer survival in the UK: a modelling study
- (2020) Amit Sud et al. LANCET ONCOLOGY
- Chest CT accuracy in diagnosing COVID-19 during the peak of the Italian epidemic: A retrospective correlation with RT-PCR testing and analysis of discordant cases
- (2020) Zeno Falaschi et al. EUROPEAN JOURNAL OF RADIOLOGY
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Influenza in patients with cancer after 2009 pandemic AH1N1: An 8‐year follow‐up study in Mexico
- (2019) Diego Ángeles‐Sistac et al. Influenza and Other Respiratory Viruses
- Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas
- (2009) Isabelle Ray-Coquard et al. CANCER RESEARCH
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started